Top 4 Undervalued Stocks to Watch in 2024
Smart investors are always trying to get the best possible deal on whatever security or asset they are buying. The better the deal, the higher the chance of generating a substantial ROI. To do so, we use a wide array of tools to try and analyze today's top undervalued stocks. Within this report you'll find 4 stocks selling below intrinsic value with growth potential.
By clicking the link above you will automatically opt-in to receive emails from ActivaTrade
Shares Stats
| Shares Outstanding | 1,765,469,952 |
| Shares Float | 1,737,645,242 |
| Shares Short | 15,429,290 |
| Insider Holdings | 10% |
| Institution Holdings | 70.00% |
About AbbVie Inc
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), mantle cell lymphoma, waldenström's macroglobulinemia, marginal zone lymphoma, and chronic graft versus host disease; VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; AndroGel for males diagnosed with symptomatic low testosterone; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production. The company was incorporated in 2012 and is based in North Chicago, Illinois.
General
| Name | AbbVie Inc |
| Ticker | ABBV |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Drug Manufacturers-General |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 47,000 |
Highlights
| Analyst Target | 121.52 |
| Market Cap | 183,245,373,440 |
| PE Ratio | 49.38 |
| PEG Ratio | 1.28 |
| EBITDA | 22,169,999,360 |
Financials
| Curr Year EPS Estimate | 12.44 |
| Next Quarter EPS Estimate | 2.81 |
| Profit Margin | 0.10 |
| Return on Assets | 0.08 |
| Return on Equity | 1.88 |
| Revenue | 45,803,999,232 |
| Earnings Per Share | 2.72 |
| Revenue Per Share | 27.48 |
| Gross Profit | 31,747,000,000 |
| Quarterly Revenue Growth | 0.59 |
Valuation
| Trailing PE | 38.15 |
| Forward PE | 8.49 |
| Price/Sales (Trailing 12 Mt.) | 3.84 |
| Price/Book (Most Recent Quarter) | 14.19 |
Dividend
AbbVie Inc pays out a dividend of $4.84 per share, with a dividend yield of 3.59%.
ABBV's last dividend payment was made to shareholders on May 14, 2021.
They pay out 47.19% of their earnings out as a dividend.
Recent Dividends
| May 15, 2024 | $1.55 |
| Feb 15, 2024 | $1.55 |
| Nov 15, 2023 | $1.48 |
| Aug 15, 2023 | $1.48 |
| May 15, 2023 | $1.48 |
| Feb 15, 2023 | $1.48 |
| Nov 15, 2022 | $1.41 |
| Aug 15, 2022 | $1.41 |
Top 3 Materials Stocks You May Want To Dump In May
Three stocks in the materials sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
AbbVie Is 'Successfully Positioned To Absorb Humira Biosimilar Erosion': Analyst
Cantor Fitzgerald initiates coverage on AbbVie with an Overweight rating and a $200 price target. AbbVie is set to manage Humira biosimilar erosion, drive growth with Skyrizi, Rinvoq, and emraclidine, and achieve a high single-digit CAGR from 2024 to 2029.
Is This Nvidia's Secret Weapon? - Ad
You've likely heard about Nvidia's incredible success in AI. But without this startup's technology, Nvidia's groundbreaking AI chips simply wouldn't be possible. It's still flying under the radar. That could change very soon with a major announcement on the horizon.
Top 4 Health Care Stocks Which Could Rescue Your Portfolio This Month
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Red Lobster closes dozens of locations across the US just months after 'endless shrimp' losses
NEW YORK (AP) — Dozens of Red Lobster locations across the U.S. are on the chopping block.
Discover "U.S.'s New Money" Before Biden Wins - Ad
A new form of money has emerged in America, and it's making some folks wildly rich... (Musk and Bezos both use it). Find out how you can too in this free video.
What's Going On With Palantir Technologies Stock Today?
Last week, Palantir Technologies reported strong Q1 results, beating revenue estimates and delivering six straight quarters of GAAP profitability. It also raised its full-year guidance and aims to be the dominant AI infrastructure in the market.
GameStop, AMC, Plug Power, Rumble, Tesla: Why These 5 Stocks Are Investors' Radars Today
major U.S. stock indices closed higher, with the Dow Jones Industrial Average increasing by 0.3% to 39,558.11.
Must-See: Elon's New Invention is Absolutely Insane - Ad
When you click here and see what Elon Musk's new invention does... And how it works... You will NOT believe it. You'll tell yourself this is just science fiction. But Elon just tested this in a real human... And the result was mind-blowing.
Katy Perry and Rihanna didn't attend the Met Gala. But AI-generated images still fooled fans
NEW YORK (AP) — No, and didn't attend the this year. But that didn't stop AI-generated images from tricking some fans into thinking the stars made appearances on the steps of fashion's biggest night.
One Tech Tip: Protecting your car from the growing risk of keyless vehicle thefts
LONDON (AP) — They appear like ghosts in the night, standing outside your house, one holding up an antenna while the other crouches next to the car parked on the driveway. Within seconds, your car is gone, yet another victim amid enabled by the technology designed to make it easier to unlock and start vehicles.
Defi Coin Triggers All "Buy" Signals and Could Break Out Soon - Ad
Some are calling this the most promising DeFi project since Ethereum itself. Here's the #1 DeFi Coin Set to Soar. While Bitcoin grabs headlines, this lesser known DeFi coin is quietly gearing up for a monster rally. Experts say now is the time to buy before it reaches escape velocity.
I-95 overpass in Connecticut scorched during a fuel truck inferno has been demolished
NORWALK, Conn. (AP) — A bridge damaged in a fiery crash that kept Interstate 95 in Connecticut has been demolished.
Trump's Niece Says Ex-President Has Made It Clear He Wants To Be Authoritarian Upon Returning To Office: 'Once That Happens, He Will Not Be Stopped'
Trump's niece suggests that her uncle has a split personality, emphasizing that people are not paying enough attention to his negative traits.
The Mysterious Tale of "America's No. 1 Retirement Stock" - Ad
This factory of 53,000 employees, in Burbank, CA, was camouflaged to look like a sleepy suburb (with the help of artists, set designers, and painters from nearby Hollywood movie studios). The mysterious company behind this disappearing act is now being called "America's No. 1 Retirement Stock".
Hope Hicks Testifies On Trump's Ex-Lawyer Michael Cohen's 'Mr. Fix It' Moniker: 'Only Because He Broke It First'
The criminal trial against Donald Trump saw former Trump aide Hope Hicks take the stand Friday and discuss Michael Cohen and the "Access Hollywood" tape.
Here's How Much A Super Bowl LIX Commercial Will Cost, How Fox Corporation Stock Could Benefit
Super Bowl LIX is months away, but it's already time to talk about the commercials with a high price tag already reported.
5 Wall Street Legends Just Bought This One Stock - Ad
"If you're not at the table, you're on the menu," says former Goldman Sachs VP, Dr. David Eifrig.
Walmart Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Walmart is reportedly set to lay off hundreds of corporate employees and relocate others to its main corporate hubs.
Fraudsters target small businesses with scams. Here are some to watch out for
NEW YORK (AP) — It's never fun to be scammed, but if you're a small business owner then falling for a scam can have long-lasting effects on a business, damaging client relationships and profit.
Could Elon's New Device be Bigger than the iPhone? - Ad
According to 30-year Silicon Valley and Wall Street veteran, Eric Fry... A man who picked 41 plays that jumped 1,000%+... This mind-blowing new technology could be bigger than the iPhone. And it could make a lot of people wealthy in the coming months and years.
Ukraine May Need To Negotiate With Russia To End War, Says Top Intel Officer: 'Both Sides Are Jockeying For The The Most Favorable Position'
Ukraine may need to negotiate with Russia to end the war, as suggested by a senior intelligence official. Negotiations could begin in the second half of 2025.
Last Week's Worst-Performing Stocks: Are These 15 Large-Cap Stocks In Your Portfolio? (April 28-May 4, 2024)
15 large-cap stocks had a rough week, with CVS, Starbucks, and DoorDash all taking major hits. Analysts have lowered price targets on many.
Shhh! This Is One Great Coin... - Ad
Shhh! I truly believe this crypto could be one of the top earning cryptos of all time... In fact, in the coming bull run... this one coin could have the potential to bank 10x... 50x... and even 100x.
Once Vehicles For Republican Presidents To Connect With Southern Whites, Motor Sports Are Shifting Away From Trump
The fading sway of Trump in motor sports suggests the breakup of the conservative-racing connection, as shown by recent developments at the Miami Grand Prix.
Influencers Barred From Promoting Betting And Narcotics Under New Spanish Law
By Lucía Tedesco via El Planteo, adapted for Benzinga.
Mystery of the Rich and Connected Revealed - Ad
Former Goldman VP reveals a mysterious "Gold Bank" with huge upside potential... Last time we shared this, some folks could have seen a 995% gain. Don't be surprised if you've never heard of this -- most haven't. But he's sharing all in this new video.
Why Hims & Hers Health Stock Is Rising Today
After the market close on Monday, Hims & Hers Health reported strong first-quarter results that included revenue of $278.2 million, representing a 46% increase from $190.8 million in the first quarter of 2023. The number beat analyst estimates of $270.382 million.
US Stocks Eye Fourth Positive Session Despite Hawkish Fed Remarks; Disney, Palantir Tumble; Treasury Yields Fall: What's Driving Markets Tuesday?
Wall Street experienced a quiet session during morning trading on Tuesday, influenced by a lack of significant economic data and minimal updates on earnings from major large-cap companies.
Forget AI, Imperium Is Expected to Grow 320,000% In 3 Years - Ad
Three of the world's biggest AI companies -- Google, Nvidia and Intel -- have even partnered with my No. 1 Imperium company to get on this massive mega trend. The average investor hasn't caught on yet, but you can still invest in my No. 1 Imperium company for just $10 a share.
Angel Reese, Cardoso debuts watched widely on fan's livestream after WNBA is unable to broadcast
The WNBA debuts of Angel Reese and Kamilla Cardoso were widely watched on a social media who stepped in when the league's app couldn't broadcast the game.
Deepfake of principal's voice is the latest case of AI being used for harm
The most recent criminal case involving artificial intelligence , where police say a principal was framed as racist by a fake recording of his voice.
Why Gold Is Headed Above $3,000 - Ad
Many experts believe gold is headed to $3,000/oz. or even higher. As this rally picks up... most investors will likely run out and buy an ETF, a gold mining stock, or even bullion. But there's actually a much better way to profit from the emerging gold boom (with just $5.)
Elon Musk, Mark Zuckerberg Missing From AI Safety Board, MKBHD Reviews Rabbit R1 And More: This Week In AI News
This week was full of news from the tech and investment world, including Musk's thoughts on AI, Wood's significant trades, Intel's popularity on Reddit, and MKBHD's review of a new AI device.
Hims & Hers Health CEO Under Fire After Expressing Support For Pro-Palestinian Student Protesters, Company Stock Plummets
Hims & Hers Health Inc. (NYSE: HIMS) stock was hit significantly on Friday following its CEO's public support for pro-Palestinian protesters.
Earn Instant Cash Flow (using THIS tactic) - Ad
Can you imagine earning $1,118,721/hr? That's what greedy Wall Street elites have been pocketing for 22 straight years. And now it's available to you.
'Dogecoin Killer' Shiba Inu Burn Rate Spikes 800%, Crypto Market Rallies As Sentiment Soars And More: This Week In Cryptocurrency
The week was a rollercoaster ride for the cryptocurrency market. The crypto world was buzzing with news, from Shiba Inu’s surging burn rate to speculation of certain altcoins becoming irrelevant.
Sony Pictures and private equity firm Apollo express interest in buying Paramount for $26 billion
Sony Pictures and the private equity firm Apollo Global Management have expressed interest in buying Paramount Global for $26 billion, according to a person familiar with the details.
$25 AI Stock Could Deliver Life-Changing Windfall - Ad
Discover a company at the forefront of the AI revolution, with up to $1 billion in government-backed contracts and 1,372 patent applications. Trading at just $25 a share...
Tesla Rival Nio To Roll Out Mass-Market EV Brand In May: Report
Nio Inc's expansion strategy gains momentum with the imminent launch of its mass-market EV model, targeting affordability without compromising quality. CEO William Li's confirmation of the Onvo sub-brand's focus on challenging Tesla's Model Y underscores Nio's commitment to global competitiveness.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.